The QualityStocks Daily Newsletter for Friday October 9th, 2009 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters


Stock Rich (IOVE)


OTC Picks (XMDC)


Bull in Advantage (BDGR)

The QualityStocks Daily

Trio Gold Corp. (TGK.V) (TROOF)

Today we choose to highlight Trio Gold Corp (TGK.V) (TROOF) as "One to Watch" next week, here at the QualityStocks Daily Newsletter.

Trio Gold Corp. is a junior mining company that lists on the Pink Sheets and the TSX Venture Exchange. The Company's commitment is to the exploration, analysis, and evaluation of precious mineral properties on an international scale. Trio searches for excellent reserves and deposits with significant mining and market value. Headquartered in Calgary, Alberta, Trio Gold Corp. went public in 1987.

Trio employs experienced geologists and geochemists as well as knowledgeable entrepreneurs and financial administrators. They have a core team of highly qualified people to ensure the research and assessment of each property is accurate and precise. Their interests include gold, silver, and copper.

The Company's projects include the Rodeo Creek Property - Carlin Trend, Nevada. The Company owns a 100 percent interest in the Rodeo Creek property. It is at the north end of the famed "Carlin Trend" in Elko County, Nevada, and approximately 56 km northwest of the town of Carlin. The property comprises 29 contiguous mineral claims covering an area of 547 acres (221 hectares).

On May 19, 2009, Trio Gold Corp. announced that they signed a USD $2,000,000.00 Option Agreement with Coastal Pacific Mining Corp. to explore Trio's wholly owned twenty-nine claim Rodeo Creek property. Coastal Pacific Mining Corp. is a public trading company with stock symbol CPMCF. Under the terms of the agreement, Coastal Pacific Mining Corp. had until July 15, 2009 to complete their due diligence and provide USD $1,000,000 for drilling on the property.

Subsequently, on July 31, 2009, Trio Gold Corp. and Coastal Pacific Mining Corp. (CPM) announced that they amended their May 19th, 2009 Option Agreement. Under the amended terms, Trio has granted CPM a non-exclusive extension until October 15th, 2009 to provide US$ 1,000,000 in exploration funds for Trio's Rodeo Creek property.

CPM can earn a 40 percent working interest in the property by providing a total of US$2,000,000 by July 15th, 2010. CPM has the right to earn 70 percent interest by completing a bankable feasibility. Trio has received 300,000 shares of CPM in accordance with the original agreement.

We're tracking Trio Gold Corp (TGK.V) (TROOF) on our radar screens as "One to Watch" next week, here at the QualityStocks Daily Newsletter.

Trio Gold Corp (TGK.V) (TROOF) closed Friday's trading session at $0.13 up 30.00 percent. Volume was 1,072,500.

China Crescent Enterprises, Inc. (CCTR)

Recently, PennyOmega.com and Stock Marketing Inc. reported on China Crescent Enterprises, Inc. (TROOF) DrStockPick.com, Stock Stars, HotOTC.com, Stock Rich, Cool Penny Stocks, Penny Invest, StockEgg.com, OTC Picks, Penny Stock Finder did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.

Trading on the OTCBB, China Crescent Enterprises, Inc. is a technology leader in the rapidly developing Chinese market. The Company specializes in software engineering, high quality software development, and digital multimedia outsourcing services delivered to customers worldwide. China Crescent Enterprises is also a systems integrator and value added reseller of major global hardware brands in the Chinese domestic market. China Crescent Enterprises, Inc. has their headquarters in Dallas, Texas, with operations in Shanghai and Beijing, China.  

Crescent assists Western clients in realizing the advantages of the high quality, low cost technology products, and services available from China. They also assist Western clients in localizing products and services to realize the significant growth potential available by expanding into the Chinese Market. China Crescent, through understanding the differences in business processes, communications, and cultures between the Untied States and China, provides their customers with an environment for global relationships and transactions.

Today, China Crescent Enterprises, Inc. and NuMobile, Inc. announced signing a letter of intent (LOI). This is for a mobile computing project worth approximately $1 million in potential revenue with a company in Kenya. The Companies have further announced that the transaction is anticipated to close in conjunction with the upcoming Trade Mission to Kenya. The two companies entered into a partnership to combine NuMobile's smartphone and mobile computing technology solutions with China Crescent's systems integration expansion into East Africa in the launch of WiMax services in Africa.

China Crescent Enterprises, Inc. reported over $40 million in revenue in both 2007 and 2008. The Company has forecasted reporting $50 million in profitable revenue in 2009. China Crescent is now registering in China to provide E-Commerce services to improve their sales potential of smartphone and mobile computing solutions.

China Crescent Enterprises, Inc. (TROOF) closed today at $0.0502 down 10.36 percent. Volume was 11,128,470.

Gulf Resources, Inc. (GFRE)

Today, Lebed.biz reported on Gulf Resources, Inc. (GFRE) Wall Street Grand did earlier, and today we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.

Gulf Resources, Inc. is a leading manufacturer of bromine, crude salt, and specialty chemical products in China. Trading on the OTC Bulletin Board, the Company operates through two wholly owned subsidiaries. These are Shouguang City Haoyuan Chemical Company Limited, (SCHC) and Shouguang Yuxin Chemical Industry Co., Limited (SYCI). The Company believes that they are one of the largest producers of bromine in China. Gulf Resources became a U.S. publicly traded company in December 2006.

Elemental Bromine is for manufacturing a broad spectrum of compounds used in industry and agriculture. Through SYCI, Gulf Resources, Inc. manufactures chemical products utilized in a variety of applications. These include oil & gas field explorations and as papermaking chemical agents. Applications also include inorganic chemicals, such as industrial refrigeration chemicals. The Company has also developed proprietary pharmaceutical intermediary products that await commercialization. They manufacture their chemical products using two production lines with a combined annual production capacity of 24,000 tons.

Gulf Resources explores bromine and manufacture their bromine and crude salt products in six facilities in Shandong province through their SCHC subsidiary. Their current installation includes more than 3,400 wells. This brings their bromine production capacity to an estimated 31,000 tons yearly. They continue to increase the yield from their reserves as they continue installing new production equipment.

Today, Gulf Resources, Inc. announced that the Company will effect a one-for-four reverse split of the Company's common stock and trade on the Over the Counter Bulletin Board under the new ticker symbol "GRUS.OB". This is effective at the open of the market on Monday, October 12, 2009. Every four shares of common stock before the reverse stock split shall represent one share of common stock after the reverse stock split. As a result of the reverse split, Gulf Resources, Inc. will have approximately 30,542,211 shares of common stock issued and outstanding.

Gulf Resources, Inc. (GFRE) closed today's session at $2.08 up 12.43 percent. Volume was 1,285,194.

Global Health Ventures Inc. (GHLV)

Today we are highlighting Global Health Ventures Inc. (GHLV), here at the QualityStocks Daily Newsletter.

Global Health Ventures Inc. is a Specialty Pharma enterprise with a focus on the Over-The-Counter market.  Trading on the OTC Bulletin Board, the Company has a new proprietary platform technology that delivers many approved drugs via the sublingual (under the tongue) route. They currently have five products in late stage development and several more underway. Global Health Ventures Inc. has their corporate headquarters in Vancouver, British Columbia, Canada.

The sublingual (under the tongue) route is a unique method that delivers low dose drugs directly to the blood stream. It does this while bypassing all the side effects of digestive and liver system breakdowns, and while maintaining product efficacy.

On August 31, 2009, Global Health Ventures Inc. announced the start of a series of pharmaceutical tests on their "Super Stimulus" sublingual formulation product under the code name GLV-0905. The product, placed under the tongue, allows for swift and highly efficient absorption. GHLV-0905 is the Company's active energy product. They designed this product for sport, work, study, and general daily life. Users will put a small piece of the film under their tongue and get a quick, efficient, long lasting boost of energy without sugar or calories. Global Health Ventures Inc. is scheduling the Super Stimulus product to be ready for marketing in late 2009 or early 2010.

On Tuesday of this week, Global Health Ventures Inc. announced that they are about to begin an investment road show, starting in Montreal, Quebec this week, and then presenting in London, England.  Global Health is raising via a Private Placement proceeds of up to $2,000,000 USD. They are currently negotiating the terms of the investment.

If successful, the Company will use the proceeds of this financing to carry out the clinical trials needed for approval of their lead life-style pharmaceutical product, (X-Excite). This is a male sexual enhancement drug. The developed this drug to work sublingually.  X-Excite is a new formulation of an existing sexual enhancement drug, which is designed to enter rapidly the blood system, maximizing its efficacy and performance.

 "Our new platform technology allows us to deliver many already approved drugs sublingually (under the tongue) thus avoiding many side effects these drugs may have, yet maintain the products efficacy. Major pharmaceutical companies are facing a steep revenue decline because of looming patent expirations and lack of innovation for new drugs. Specialty Pharma's and biotech companies are becoming highly desirable due to their pipeline of new drugs and solid innovations," said Dr. Hassan Salari, President, and CEO.

Global Health Ventures Inc. (GHLV) closed Friday's session at $0.64 up 28.00 percent. Volume was 3,410,518.

PolyMedix, Inc. (PYMX)

SmallCap Voice reported last week on PolyMedix, Inc. (PYMX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

PolyMedix, Inc. is an emerging biotechnology company that trades on NASDAQ's OTCBB. The Company is developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics - non-peptide small molecule drug candidates that mimic the activity of proteins. The Company has their headquarters in Radnor, Pennsylvania.

The Company's antibiotic compounds have a mechanism of action distinct from those of current antibiotic drugs.  It is a mechanism whose intent is to make bacterial resistance unlikely to develop. The Company's goal is to develop these as rapidly acting antibiotics for serious systemic and local infections. The Company plans to continue the development of polymeric formulations as antimicrobial biomaterials. These can find use as additives to paints, plastics, and textiles to create self-sterilizing products and surfaces.

Last week, PolyMedix announced that they received patent protection for certain exclusively licensed intellectual property by the issuance to the University of Pennsylvania of U.S. patent number 7,590,517, "Methods, Systems, and Computer Program Products for Computational Design of Amphiphilic Polymers." This patent claims the underlying process and implementation of two proprietary computational methodologies. One is PACE™ (Proteomic Assisted Computational Engine). The other is GOLDYN™ (Global Optimization of Long-time Dynamics force field), useful for the de novo design of small molecule mimetics.

In addition, last week, PolyMedix, Inc. announced that they have initiated dosing and commenced a second clinical trial. It is a Phase 1B pilot proof of concept study in the U.S. with their anticoagulant reversing agent PMX-60056 under an Investigational New Drug application (IND) filed with the U.S. Food and Drug Administration (FDA). PMX-60056 represents a new class of drug, which PolyMedix calls a heptagonist. It is believed to be the only reversing agent for heparin and the Low Molecular Weight Heparins (LMWH) in clinical development. Heparin and LMWH are widely used anticoagulants (drugs to prevent blood clotting). They have the risk of potentially serious bleeding side effects.

PolyMedix, Inc. (PYMX) closed Friday's trading session at $1.08 up 8.00 percent. Volume was 531,274.

Health Discovery Corporation (HDVY)

Today we are highlighting Health Discovery Corporation (HDVY), here at the QualityStocks Daily Newsletter.

Health Discovery Corporation operates as a pattern recognition company. They use mathematical techniques to analyze large amounts of data to uncover patterns in the United States. The Company believes that the realization of personalized medicine can only be accomplished with the development of molecular diagnostic tests. They believe this development is possible only through advanced mathematical pattern recognition techniques as demonstrated by their SVM and RFE-SVM technology. Health Discovery Corporation trades on the OTC Bulletin Board and they have their headquarters in Savannah, Georgia.

Health Discovery Corporation's approach to molecular diagnostics allows for specific, effective diagnosis and treatment. They apply state-of-the-art computer technology and mathematical modeling to available and emerging data sources. By so doing, they aim to uncover meaningful relationships useful in prevention, detection, and treatment of disease.

Health Discovery Corporation's principal intellectual property includes Support Vector Machines (SVM), Recursive Feature Elimination (RFE), and Fractal Genomic Modeling (FGM). Support Vector Machines, rooted in the Statistical Learning Theory developed by Vladimir Vapnik, gained attention from the pattern recognition community due to its theoretical and computational merits. Statistical Learning Theory, the backbone of Support Vector Machines, provides a new framework for modeling learning algorithms, merges the fields of machine learning and statistics, and inspires algorithms.

RFE-SVM, created by Health Discovery Corporation's scientific mathematicians, is used to find discriminate relationships within clinical datasets and within gene expression datasets created from micro-arrays of tumor versus normal tissues.  Using RFE-SVM, the Company's scientists have been able to access specific genetic information that the previously most advanced bioinformatics techniques missed. The Company holds the only issued patents in the world for this technology.

Health Discovery Corporation acquired the Fractal Genomics Modeling (FGM) to find discriminate relationships within clinical datasets as well as within gene expression datasets created from micro-arrays of disease versus normal tissues. Fractal Genomics Modeling technology is designed to study complex networks. An example is genes inside a living organism.  FGM uses a new approach toward modeling network behavior to generate rapidly diagrams and software simulations that facilitate prediction and analysis.

Health Discovery Corporation (HDVY) closed Friday's session at $0.26 up 55.88 percent. Volume was 2,490,984.

So Act Network, Inc. (SOAN)

Today, Market Pulse and NanoCap Gems reported on So Act Network, Inc. (SOAN) and we are highlighting the Company too, here at the QualityStocks Daily Newsletter.

So Act Network, Inc. is focusing on their Internet search engine and networking Web site. They offer live So Act Search Engine and So Act Network.  Founded in 2005, the Company has their corporate headquarters in Humble, Texas. They trade on NASDAQ's OTCBB.

So Act Network, Inc.'s technologies provide a global social network. Here, their members are free to accomplish and promote all of their important goals without being subjected to spam or ads. In addition, they can accomplish and promote their goals without having their personal information used by marketers. The So Act Network consists of Conversations, a zero-spam communication tool that combines email and real-time chat with security and archiving, as well as allows a user to have as many simultaneous conversations going as he or she wants by cloning the tool.

Along with the above-mentioned, some of the tools that provide benefits to So Act members include the ability to form groups that help build business, develop new ideas, study and learn, promote causes,  and connect with likeminded individuals. Tools also include a media drive that allows members to upload, secure, and file share every important file on their computer. In addition, members can utilize a press club so they can share their important news with their followers and the media

So Act Network, Inc. announced on September 9, 2009 the official launch of their platform and marketing campaign.

"So Act is a new type of social network with no spam and no ads where you can get important stuff done without distractions," said Greg Halpern, President, So Act Network. "Businesses can network customers, suppliers, distribution or just new ideas. Students can study together. Members can organize a global community of likeminded thinkers who are working on the same things or they can solve problems and invite the world to help.

So Act Network, Inc. (SOAN) closed Friday's trading session at $2.40 down 2.04 percent. Volume was 22,391.

Unigene Laboratories Inc. (UGNE)

We are highlighting Unigene Laboratories Inc. (UGNE), here at the QualityStocks Daily Newsletter.

Unigene Laboratories, Inc. is a biopharmaceutical company focusing on the oral and nasal delivery of large-market peptide drugs. Unigene's patented oral delivery technology has successfully delivered, in preclinical and/or clinical trials, various peptides. These include calcitonin, PTH, and insulin. The Company designed their patented manufacturing technology to produce cost-effectively, peptides in quantities sufficient to support their worldwide commercialization as oral or nasal therapeutics. Unigene Laboratories Inc. trades on the OTCBB and they have their headquarters and manufacturing facility in Boonton, New Jersey. They also have a Research & Development Facility in Fairfield, New Jersey.

Unigene is targeting their initial efforts on developing calcitonin and PTH-based therapies due to the size of the global osteoporosis market. Fortical® is their nasal calcitonin product for the treatment of postmenopausal osteoporosis. This product received FDA approval and launched in 2005. Unigene has licensed the U.S. rights for Fortical to Upsher-Smith Laboratories. They have licensed worldwide rights for their oral PTH technology to GlaxoSmithKline and worldwide rights for their calcitonin manufacturing technology to Novartis.

Unigene Laboratories Inc.'s technologies for the large-scale recombinant manufacturing of peptides and formulations for compliance-friendly delivery are capable of being applied to a broad spectrum of peptide and protein-based therapeutics.  Their clinical and R&D peptide programs cover diverse therapeutic areas. These include osteoporosis, osteoarthritis, satiety/obesity, endometriosis, prostate cancer, pain, site-directed bone growth (SDBG), and diabetes.

Last month, Unigene Laboratories, Inc. reported that the U.S. District Court, Southern District of New York, confirmed the validity of Unigene's patent on Fortical®. The court issued an order permanently enjoining Apotex Inc. and Apotex Corp. from further infringement of the patent. The motion of the plaintiffs, Unigene and their licensee Upsher-Smith Laboratories, for summary judgment in the case was granted. The request for summary judgment by Apotex was denied.

Today, Unigene Laboratories Inc. (UGNE) closed at $1.74 up 7.41 percent. Volume was 433,967.

The QualityStocks Company Corner

Advanced Visual Systems (AVSC)
Omnicity Corp. (OMCY)
Kraig Biocraft Laboratories (KBLB)
General Environmental (GEVI)

Zaldiva, Inc. (ZLDV)
Sunwin International Neutra (SUWN)
310 Holdings, Inc. (TRTN)
BIO-key International (BKYI)

Advanced Visual Systems Inc. (AVSC)

The QualityStocks Daily Newsletter would like to spotlight Advanced Visual Systems Inc. (AVSC) Today, Advanced Visual Systems Inc. closed trading at $0.80, which was up 14.29 percent. Their volume today was 91,036 shares.

Advanced Visual Systems Inc. (AVSC) develops and distributes software products that are used in multiple sectors of the business and technical industries to present various forms of data in easily understandable graphic representations. Offering a complete line of software products and consulting services, the company is widely recognized as the data visualization industry leader, boasting over 2,500 international customers.

The company has distinguished itself from other companies in the fast-growing data visualization and analytic fields through its comprehensive range of software offerings and sixteen years of product innovation. Together, these competitive advantages have enabled AVS to capitalize on a growing marketplace for graphics-based analytic technology.
Advanced Visual Systems’ premiere products include OpenViz, a data visualization engine designed to provide interactive visual analysis to business applications; AVS/Express, a software development system designed for programmers as well as individual end-users; Toolmaster, a comprehensive graphics library that is used to create charts and graphs; and Gsharp, a Windows and Unix-based software product that generates technical charts and graphs.

The company collaborates with its partners to provide clients with every possible technology advantage. These partners include Microsoft, Oracle, Hewlett-Packard, Sun Microsystems, and other industry leaders. With a comprehensive product line and an experienced management team, no other software company offers the range of developer-friendly products and capabilities as AVS.

Advanced Visual Systems Inc. Blog

Advanced Visual Systems Inc. News:

Advanced Visual Systems Improves Real-Time Performance Monitoring for Major Global Enterprise

Data Visualization Software from Advanced Visual Systems Adds Powerful Functionality to Business Intelligence Dashboards

Globalequityreport.com Announces an Investment Report Featuring Software Services Company Advanced Visual Systems Inc.

Omnicity Corp. (OMCY)

The QualityStocks Daily Newsletter would like to spotlight Omnicity Corp. (OMCY) Today, Omnicity Corp. closed trading at $0.51, which was up 10.87 percent. Their volume today was 32,750 shares.

Omnicity Corp. (OMCY) announced that they have agreed with QualityStocks to be featured in The Small Cap QualityStocks Daily Newsletter, QualityStocks Daily Blogs, and Message Boards.

Yesterday, Omnicity Corp. (OMCY)announced that it had been awarded its first contract to provide broadband services to the State of Indiana. The company was the winning bidder in an RFP to provide services for the Department of Natural Resources (DNR) with the State of Indiana.

Omnicity Corp. (OMCY) provides broadband access, including advanced services of voice, video and data, in un-served and underserved small and rural markets. The company aims to be the premier consolidator of rural market broadband nationwide. Leveraging management expertise, Omnicity’s strategy is to provide a total broadband solution and continue rapid growth through acquisitions, organic growth and partnerships with Rural Electric Municipal Cooperatives and Rural Telephone Companies.

The company’s target markets are locations better suited to wireless transmissions than traditional hard-wire operators. It has been estimated that at least 40 million rural and small market homes, businesses, government agencies and schools have inadequate high-speed Internet service, representing a large growth opportunity.
Building a nationwide wireless network, Omnicity will be able to deliver high-speed Internet access to rural subscrib­ers more cost-effectively than traditional cable or fiber optic models since hard-wire systems are gener­ally much more expensive to build than wireless networks. Reduced network development costs means lower infrastructure costs per subscriber for wireless operators as compared to comparably-sized traditional hardwire fiber-optic systems.

Omnicity is led by an experienced broadband operations team with extensive wireless broadband/ISP expertise as well as the capability to consolidate large numbers of businesses through a strategic roll-up strategy. Over the next five years, the company projects a growing customer base of 170,000 subscribers, increasing margins and growing revenues of nearly $87 million. Disclaimer

Omnicity Corp. Blog

Omnicity Corp. News:

PennyOmega Announces Stock Alert on CBAI, OMCY, NHYT

Omnicity Corp. to Be Featured in Small Cap Stock Newsletter QualityStocks Daily

Omnicity Wins First State Contract With Indiana DNR

Kraig Biocraft Laboratories, Inc. (KBLB)

The QualityStocks Daily Newsletter would like to spotlight Kraig Biocraft Laboratories, Inc. (KBLB) Today, Kraig Biocraft Laboratories, Inc. closed trading at $0.0160, which was up 4.58 percent from yesterday's close. Their volume today was 59,331 shares.

Kraig Biocraft Laboratories, Inc. (KBLB) a biotechnology company, has their focus on developing high performance polymers and technical fibers. The company is utilizing their proprietary genetic engineering technology to develop and produce polymers and protein-based materials, including Spider silk, which may have numerous commercial and consumer applications.

Kraig Biocraft Laboratories, Inc. (KBLB) is working with university scientists and laboratories to create these new polymers that have potentially broad applications in the multi-billion dollar marketplace for high performance polymers. The company sponsors and collaborates on research projects within university genetic engineering laboratories as a means of utilizing the greatest minds in their field.

Spider Silk is one of the strongest fibers produced in nature. The spider's repelling silk is of particular commercial interest since it is both extremely strong and extremely flexible. Although exciting commercial opportunities exist for the natural polymer, there is no known way to produce the fibers in commercial quantity. KraigLabs, in cooperation with two leading universities, has acquired proprietary genetic engineering technology to unlock the mystery.

CEO Kim Thompson leads the company with formal education in the fields of economics and law. With interest in genetic engineering dating back to the 1970s, Mr. Thompson has invented a pending provisional patent application for a number of organic polymers. This patent application has been assigned to benefit Kraig Biocraft and is a central part of the company's efforts in bringing those inventions to the market. Disclaimer

Kraig Biocraft Laboratories, Inc. Blog

News for Kraig Biocraft Laboratories Inc.

Kraig Biocraft Laboratories, Inc. Greatly Exceeds Its Performance Goals

SectorWatch.biz: Paving the Way for Spider Silk

The following is an investment opinion release issued by EmergingStockReport.com

General Environmental Management (GEVI)

The QualityStocks Daily Newsletter would like to spotlight General Environmental Management Inc. (GEVI). Today, General Environmental Management Inc. closed trading at $0.58, which was up 1.75 percent. Their volume today was 5,000 shares.

General Environmental Management Inc. (GEVI) announced that they have retained General Pacific Partners (GPP), a financial advisory firm, to explore and assist in the evaluation of wastewater business acquisition opportunities in California and the Western United States.

General Environmental Management Inc. (GEVI) is an integrated environmental service firm that provides field services, remediation, transportation, EHS compliance services, on-site technical services and off-site treatment. The company enables enterprises in the Western United States to meet regulatory requirements for the disposal of hazardous and non-hazardous wastes.

GEM currently operates eight field service locations and one treatment, storage, disposal facility (TSDF) servicing all markets in the Western United States. The company’s clients include utility, chemical, petroleum, petrochemical, pharmaceutical, transportation, and industrial firms, as well as educational institutions, environmental service companies, and government agencies.

The company’s integrated environmental services are all monitored and managed through its enterprise software, GEMWare, for the tracking of all activities from the managing, handling, packaging, and transportation of waste to final recycling, treatment or disposal. GEMWare allows customers to monitor remote waste activities from one location, and has been specifically beneficial for the environmental manager responsible for multiple sites.

GEM’s primary focus is on finding a reuse or recycle option for their clients to reduce the amount of waste in our environment. The company utilizes the best innovations, technology, facilities, logistics, personnel and information systems to offer unrivaled environmental services, while helping clients determine the most appropriate, compliant, and cost effective means for disposing various types of waste. Disclaimer

General Environmental Management Inc. Blog

General Environmental Management Inc. News:

SectorWatch.biz Issues MarketStats on Water Treatment and Remediation Companies GEVI, NLC, AWK, VE, PLL and SHAW

General Environmental Management Signs Letter of Intent to Acquire Santa Clara Waste Water

SectorWatch.biz Issues MarketStats on Environmental Remediation Companies GEVI, CLH, WM, TTEK, SHAW and URS

Zaldiva, Inc. (ZLDV) Identifies Multiple Acquisition Candidates

Zaldiva, Inc. a leader in Pop Culture collectibles, comic books, memorabilia and auctions, today detailed its acquisition strategy as it continues to focus on rolling-up smaller comic and collectibles retailers under the Zaldiva brand. The company has identified its first 5 targets for acquisition.

“We see the comic and collectibles industry being in a very similar situation to the video rental business of days gone by,” stated Nicole Leigh, CEO of Zaldiva, Inc. “Along came Blockbuster and the whole landscape changed. These smaller comic retailers, the ‘mom and pop’ stores, don’t have the infrastructure to compete in the marketplace. We’ve built a solid foundation with our online www.zaldiva.com store and have backed it up with a successful retail location that integrates eBay online auctions.”

Leigh added, “When we talk about ‘rolling up’ or ‘acquiring’ other retailers we are looking at comic book companies with large ’subscriber’ bases, meaning recurring monthly revenues. Margins in this business are typically 50% plus, and with our backend and online infrastructure we believe we can maximize their revenues and profitability.”

Discussing comic book collecting, Leigh commented, “The one remaining bastion for comic speculation remains in online auction sites such as eBay; but even there, comic books remain a buyer’s market. The highest price paid for a comic book is $350,000 for Marvel Comics No. 1 bought by Jay Parrino (USA) in November 2001.”

“We are also looking at some of the convention businesses, as these can produce substantial revenue with huge exposure to our target market. We recently announced a JV with InvestComics of West Palm Beach, Florida. The joint venture will utilize both companies World Wide Web presence to increase market share and brand awareness in the comic and collectibles industry,” concluded Leigh.

Sunwin International Neutraceuticals, Inc. (SUWN) Secures a One-Year Exclusivity Agreement with Hunan Fuhui Flavors

Sunwin International Neutraceuticals, Inc., a provider of zero calorie natural sweeteners (stevia), veterinary medicines and feeds prepared from 100 percent natural herbal ingredients, recently announced that the company has secured an exclusive one-year distribution agreement with Hunan Fuhui Flavors Co. Ltd. to distribute stevia extract within Hunan province, located in Southern China, with more than 64 million residents.

Under the terms of the agreement, Sunwin International Neutraceuticals will provide technical and marketing support to Hunan Fuhui’s sales representatives within the Hunan province. In addition, at least 50 tons of stevia extract must be distributed by Hunan Fuhui within the first year for this agreement to be subject to renewal.

“We are pleased to secure a strong partner in Hunan Fuhui, whose expertise as a regional distributor makes them an ideal candidate to increase Sunwin’s presence in Hunan province where stevia is commonly used as a natural sweetener,” stated Laiwang Zhang, chairman of Sunwin International Neutraceuticals.

“We have recently completed a number of expansion programs to increase our total stevia production capacity and we are particularly excited to expand our marketing efforts in this important domestic market.” Mr. Zhang concluded, “We look forward to this new partnership as we continue pursue opportunities both in China and throughout the globe to expand revenue and profits in our stevia operations.”

310 Holdings, Inc. (TRTN) Changes Name and Reports Positive 9 Month Results

Today, 310 Holdings, Inc. announced that it has changed its corporate name to JBI, Inc. The company will announce a symbol change when available. Despite a name change, JBI is still committed to investing its resources in long-term, highly sustainable growth and real value through its recently acquired subsidiaries.

JBI also announced that its unaudited, nine month consolidated pro-forma revenues totaled $10,156,919, with reported net earnings at $167,398. The company’s total assets valued at $22,486,751. Full financial details are available at www.sec.gov on the Form 8-K filed with the Securities & Exchange Commission on October 7, 2009.

John Bordynuik, JBI CEO and President, stated, “Currently, we are working to integrate the Company’s recently acquired wholly owned subsidiary Pak-It, LLC’s ‘Made In Canada’ manufacturing and marketing operations with that of JBI. Also, I am pleased that the Company is profitable in light of the recently incurred, non-recurring costs and fees associated with our recent acquisitions of Javaco and Pak-It, LLC. We are progressing with our Plastic2Oil operations and investing our profits into this business unit.”

The company will announce the date of an interactive conference call through a Press Release in the near future. Mr. Bordynuik will be available on this call to update the investment community on the company’s progress and answer investor inquiries.

BIO-key International, Inc. (BKYI) Gains National Attention

BIO-key International made a monumental announcement this week with the news that the young company will showcase their biometric solutions at the Oracle Openworld 2009 Conference which is being held at the Moscone Center in San Francisco from October 11-15, 2009.
The New Jersey based BIO-key has been gaining a renowned reputation as a pioneer in finger-based biometric identification and wireless public safety. As a charter member of the Oracle Identity Assurance Partner Alliance, BIO-key will provide hands-on product demonstrations of its state-of-the-art identification technology in booth #2520 at the above-mentioned Openworld Conference.

At the conference, BIO-key will display a variety of healthcare, retail, financial and government deployed identity solutions and will showcase ID Director for the Oracle Access Manager.

The ID Director is a valuable addition to the BIO-key family and the Oracle Identity Management platform because it requires only the touch of a finger to establish a person’s identity making this product the cutting edge of the industry.

BIO-key is led by their CEO Mike DePasquale. DePasquale brings more than 20 years of successful executive and sales and marketing experience as Director and CEO of BIO-key International. Most recently, he was President and CEO of Prism eSolutions, a company specializing in professional consulting services and online solutions for ISO-9001/14000 certification for customers in manufacturing, healthcare and government markets.

When asked about the Openworld Conference and the state of BIO-Key, DePasquale was quoted as saying, “BIO-key offers the ideal identity solution, delivering a secure, convenient and cost effective alternative that complies with government regulations and legislation such as HIPAA, Sarbanes Oxley, and the Electronic Signatures Act. Our software’s superior flexibility and accuracy provides organizations with a real competitive advantage that benefits both the end-user and the IT staff responsible for deploying and supporting ID solutions.”

BIO-key is currently trading in the $0.20 range, closing at $0.195 October 8th. With continuous news coming from the BIO-key and a strong management team in place, the Oracle OpenWorld Conference may be the avenue BIO-key needs to become a major player on Wall Street.


Sponsors of the Day

The QualityStocks Public Company Sponsor News

Advanced Visual Systems Inc. (AVSC) Advanced Visual Systems to Offer Hardware Products and Expanded Software Services



About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336